3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Squamous Cell Carcinoma of Head and Neck
1
Neoplasms
1
Leukemia, Myeloid, Acute
1
Leukemia, Myeloid
1
Leukemia
1
Head and Neck Neoplasms
1
Carcinoma
1
Interventions
fludarabine
9
Cytarabine
9
venetoclax
5
fludarabine phosphate
5
Cyclophosphamide
5
Busulfan
5
thymoglobulin
4
Tacrolimus
4
Sirolimus
4
Mycophenolic Acid
4
Methotrexate
4
Azacitidine
4
aldesleukin
3
Whole-Body Irradiation
3
Interleukin-2
3
Antilymphocyte Serum
3
asciminib
2
Thiotepa
2
Peripheral Blood Stem Cell Transplantation
2
Mitoxantrone
2
Idarubicin
2
Granulocyte Colony-Stimulating Factor
2
Filgrastim
2
Etoposide
2
Dasatinib
2
Cyclosporine
2
Bone Marrow Transplantation
2
Blood Specimen Collection
2
Behavior Therapy
2
zileuton
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Leukemia, Myeloid
×
IPI-549
×
Clear all
NCT07439211
2026-03-03
GAVEL
Dana-Farber Cancer Institute
Phase 1
Not yet recruiting
48 enrolled